The Trk inhibitors (CEP-751, AZ64, GNF-4256, and Lestaurtinib) have efficacy in NB cell lines and in xenograft models by reducing tumor growth and improving survival [46,47,48,49]. Here, NTRK1 is linked to neuroblastoma.